Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07355491 · ClinicalTrials.gov registry record
Performance Evaluation of Dream OCT: AP Study
A clinical trial of Glaucoma Patients and Retina Patients, sponsored by Intalight.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT07355491 is a study of Glaucoma Patients and Retina Patients that is actively recruiting participants, run by Intalight. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07355491, a study of Glaucoma Patients and Retina Patients, is actively recruiting participants, sponsored by Intalight.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.
Conditions Studied
Interventions
- DEVICE This is an observational study only, all patients are imaged on the investigational device
Study Locations (1)
Illinois
- Illinois College of Optometry - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07355491
The ClinicalTrials.gov registry entry for NCT07355491 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intalight, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Glaucoma Patients appearing as the primary indexed condition, and to 1 intervention - of which This is an observational study only, all patients are imaged on the investigational device is the first listed.
NCT07355491 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT07355491 about?
NCT07355491 is a clinical study titled "Performance Evaluation of Dream OCT: AP Study". This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.
What is the current status of trial NCT07355491?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-12-16. Estimated completion is 2026-04.
What conditions does trial NCT07355491 study?
This clinical trial studies the following conditions: Glaucoma Patients, Retina Patients, Eyes With Corneal Abnormality, Normal Healthy Eyes.
What interventions are being tested in trial NCT07355491?
The interventions under investigation include: This is an observational study only, all patients are imaged on the investigational device (DEVICE).
Who is sponsoring clinical trial NCT07355491?
This trial is sponsored by Intalight, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07355491 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.